SAN

77.06

+0.75%↑

UCB

249.1

+3.15%↑

SHL.DE

36.68

+2.72%↑

ARGX

584.4

+1.67%↑

VIE

31.41

+3.49%↑

SAN

77.06

+0.75%↑

UCB

249.1

+3.15%↑

SHL.DE

36.68

+2.72%↑

ARGX

584.4

+1.67%↑

VIE

31.41

+3.49%↑

SAN

77.06

+0.75%↑

UCB

249.1

+3.15%↑

SHL.DE

36.68

+2.72%↑

ARGX

584.4

+1.67%↑

VIE

31.41

+3.49%↑

SAN

77.06

+0.75%↑

UCB

249.1

+3.15%↑

SHL.DE

36.68

+2.72%↑

ARGX

584.4

+1.67%↑

VIE

31.41

+3.49%↑

SAN

77.06

+0.75%↑

UCB

249.1

+3.15%↑

SHL.DE

36.68

+2.72%↑

ARGX

584.4

+1.67%↑

VIE

31.41

+3.49%↑

Search

Opmobility

Open

SectorHealthcare

14.41 5.57

Overview

Share price change

24h

Current

Min

13.59

Max

14.89

Key metrics

By Trading Economics

Income

5M

95M

Sales

-448M

4.9B

P/E

Sector Avg

11.262

57.833

Dividend yield

3.3

Profit margin

1.945

Employees

28,258

EBITDA

72M

456M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+9.36% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

3.30%

2.47%

Market Stats

By TradingEconomics

Market Cap

-253M

2.1B

Previous open

8.84

Previous close

14.41

News Sentiment

By Acuity

50%

50%

144 / 350 Healthcare

Opmobility Chart

Past performance is not a reliable indicator of future results.

Related News

23 Mar 2026, 23:47 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 Mar 2026, 22:55 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 Mar 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 Mar 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 Mar 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 Mar 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 Mar 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 Mar 2026, 22:42 UTC

Market Talk
Major News Events

Global Equities Roundup: Market Talk

23 Mar 2026, 22:42 UTC

Market Talk
Major News Events

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 Mar 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 Mar 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 Mar 2026, 22:22 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 Mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 Mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 Mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 Mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 Mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 Mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 Mar 2026, 22:18 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 Mar 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 Mar 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 Mar 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 Mar 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 Mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 Mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 Mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 Mar 2026, 21:10 UTC

Major News Events

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 Mar 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 Mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 Mar 2026, 20:50 UTC

Market Talk
Earnings
Major News Events

Basic Materials Roundup: Market Talk

Peer Comparison

Price change

Opmobility Forecast

Price Target

By TipRanks

9.36% upside

12 Months Forecast

Average 15.31 EUR  9.36%

High 21 EUR

Low 9.2 EUR

Based on 7 Wall Street analysts offering 12 month price targets forOpmobility - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

7 ratings

3

Buy

1

Hold

3

Sell

Sentiment

By Acuity

144 / 350 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Opmobility

OPmobility SE engages in the manufacture and sale of exterior vehicle lighting systems, batteries, and electrification systems for electric mobility in Europe, North America, China, rest of Asia, South America, the Middle East, and Africa. The company operates through three segments: Exterior Systems, Modules, and Powertrain. Its Exterior Systems segment provides intelligent exterior systems; and automotive lighting systems, headlights, and signal lighting to intelligent, and other lighting products. The company's Powertrain segment offers clean energy systems comprising energy storage and emission reduction systems for various types of gasoline, diesel, hybrid, and plug-in hybrid powertrains; designs and manufactures battery systems, electronics, and power electronics components for electric mobility of trucks, buses, trains, and construction machineries. This segment also designs and manufactures hydrogen solutions, including high-pressure fuel tanks, fuel cell stacks, and integrated systems. Its Modules segment engages in the design, development, and assemble of modules (HBPO). In addition, the company provides intelligent exterior systems, including bumpers, tailgates and spoilers, and body panels; onboard energy storage and emission reduction systems comprising selective catalytic reduction and fuel systems, and filling pipes. Further, it offers modules and personalization products, which include front-end module, active grille shutter, active rollo, and interior and charge lid modules; and lighting solutions, including interior, body shell, and front and signal lighting, as well as projection system and lighting electronics. The company was formerly known as Compagnie Plastic Omnium SE and changed its name to OPmobility SE in March 2024. The company was founded in 1946 and is headquartered in Levallois-Perret, France. OPmobility SE is a subsidiary of Burelle SA.
help-icon Live chat